International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue 6 : 2357-2362
Research Article
Effectiveness of Low-Frequency Repetitive Transcranial Magnetic Stimulation to Contralesional Motor Cortex Combined with Conventional Rehabilitation in Sub-Acute Stroke: A Pilot Study
 ,
 ,
Received
Dec. 1, 2025
Accepted
Dec. 17, 2025
Published
Dec. 30, 2025
Abstract

Background: Upper limb motor impairment persists in up to 80% of stroke survivors and remains one of the most challenging goals in rehabilitation medicine. Low-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the contralesional motor cortex is supported by growing evidence as an adjunct to conventional rehabilitation, yet published data from the Indian subcontinent are sparse. This study describes the application and functional outcomes of 1 Hz rTMS to the contralesional primary motor cortex combined with conventional rehabilitation in five patients with subacute stroke.

Methods: Five patients with first-ever, unilateral, subcortical subacute stroke and Brunnstrom Stage 2 – 4 upper limb hemiparesis received low-frequency rTMS (1 Hz, 1,200 pulses/session, 90% resting motor threshold) applied over the contralesional M1, followed immediately by conventional neurological physiotherapy and occupational therapy. Outcomes assessed included the Modified Rankin Scale (mRS), Barthel Index (BI), Functional Independence Measure – Functional Assessment Measure (FIM-FAM), and the Fugl-Meyer Assessment (FMA, total score). Paired t-tests and Wilcoxon Signed-Rank exact tests were performed; effect sizes were computed as Cohen’s d and rank-biserial correlation.

Results: All five patients demonstrated consistent improvement across all outcome measures. Mean improvements: mRS −1.0 grade (21.7% reduction); BI +25.0±5.0 points (78.1% increase); FIM-FAM +26.4±5.6 points (21.1% increase); FMA +25.0±2.9 points (36.7% increase). All patients exceeded the Minimum Clinically Important Difference (MCID) for the Barthel Index (≥10 points). Effect sizes were very large (Cohen’s d: BI=5.00, FIM=4.68, FM=8.58; rank-biserial r=1.00 for all scales). No adverse events were recorded.

Conclusion: Low-frequency rTMS to contralesional M1 combined with conventional rehabilitation produced clinically meaningful and consistent functional gains across all outcome measures in all five patients with subacute stroke. These preliminary findings support the feasibility and efficacy signal of this approach and provide the impetus for a planned multicentre randomised controlled trial.

Keywords
INTRODUCTION

In India, stroke continues to be the second most common cause of death and the primary cause of acquired disability, with an estimated 1.8 million new cases reported each year.(1)  One of the most crippling aftereffects, upper limb motor impairment affects 70–80% of survivors and reduces their ability to take care of themselves, participate in their jobs, and lead fulfilling lives.(2,3) Even after decades of research on rehabilitation, a significant percentage of patients still do not fully regain hand and arm function, and the pursuit for efficient supplemental techniques continues.

 

Cortical excitability is modulated in a frequency-dependent manner by repetitive transcranial magnetic stimulation (rTMS).(4) Applying low-frequency rTMS (1 Hz) over the contralesional primary motor cortex (M1) suppresses pathological interhemispheric inhibition,(5) which is now known to be a major obstacle to motor recovery. This is the excessive transcallosal inhibition that the intact hemisphere exerts over the lesioned hemisphere.(6) The ipsilesional cortex is freed from suppression by 1 Hz rTMS, which also produces a neurobiological environment more favourable to activity-dependent plasticity during future rehabilitation.(7) For low-frequency rTMS in stroke rehabilitation, meta-analyses show standardised mean differences of 0.40–0.65 on the Fugl-Meyer Assessment Upper Extremity (FMA-UE),(7) and evidence-based recommendations support its use as a supplement to traditional rehabilitation methods for upper limb motor recovery.

 

Based on the neurobiology of motor plasticity, low-frequency rTMS can be used in conjunction with conventional rehabilitation(8,9). A "plasticity window" of roughly 30 to 60 minutes is created by rTMS administered prior to therapy, during which the threshold for activity-dependent synaptic potentiation is lowered and cortical excitability in the affected hemisphere is increased.(7) The conventional rehabilitation that follows directly exploits this window: task-specific motor practice in a more receptive cortical state promotes stronger and more durable synaptic strengthening than the same therapy administered without prior neuromodulation. All motor learning is based on the Hebbian principle, which states that neurones that fire together during the primed state wire together more efficiently.

 

Despite the growing international evidence base, published clinical data from India remain sparse. We report here five patients with first-ever, unilateral, subcortical, subacute stroke who received low-frequency rTMS to contralesional M1 combined with conventional neurological rehabilitation at our centre. We present detailed functional and independence outcome data with full statistical analysis, and reflect on what each patient’s journey revealed about the clinical promise of this approach.

 

METHODS

Study Design and Setting

This is a retrospective study conducted at the Department of Physical Medicine and Rehabilitation, in a tertiary care teaching government referral centre with an established stroke rehabilitation unit, using a convenience sampling technique. Written informed consent was obtained from all patients or their legally authorised representatives prior to enrolment. The procedures followed were in accordance with the ethical guidelines of the Indian Council of Medical Research (ICMR) and with the Helsinki Declaration of 1975, as revised in 2000. Institutional Ethics Committee approval was obtained prior to data collection. Patient data have been anonymised.

 

Patient Selection

Patients were eligible if they had sustained a first-ever, unilateral, subcortical ischaemic or haemorrhagic stroke confirmed on CT or MRI, were in the subacute phase (7 days to 6 months post-onset), and had upper limb impairment at Brunnstrom Stage 2–4. Patients were excluded if they had contraindications to TMS (metallic cranial implants, pacemakers, history of epilepsy), severe cognitive impairment (MMSE <24), recurrent stroke, cortical or brainstem lesions, or pregnancy.

 

Intervention Protocol

Each session comprised two sequential components delivered five days per week:

(1) Low-frequency rTMS to Contralesional M1 (approximately 20 minutes): Inhibitory 1 Hz continuous rTMS was applied over the contralesional primary motor cortex (M1) using a standard figure-of-eight coil with anatomical landmark-based positioning (hand knob area of the motor cortex contralateral to the hemiplegic limb, identified using 10-20 EEG scalp coordinates). Protocol parameters: frequency 1 Hz; 1,200 pulses per session; intensity 90% of resting motor threshold (RMT). RMT was determined at the first session using the standard minimum stimulator output method and rechecked at weekly intervals. No high-frequency or ipsilesional stimulation was applied.

 

(2) Conventional Rehabilitation (45 minutes, immediately following rTMS): Standardised neurological rehabilitation combining physiotherapy and occupational therapy, delivered within the cortical plasticity window opened by rTMS. Components included passive and active-assisted range of motion exercises, neurodevelopmental facilitation (Bobath concept), task-specific upper limb practice, postural control training, and functional activity retraining tailored to each patient’s deficit profile and Brunnstrom stage.

 

Sessions were conducted five days per week. The total number of sessions varied across patients (4–24 sessions) based on the duration of hospital admission and individual clinical progress.

 

Outcome Measures

All assessments were performed at baseline (pre-intervention) and at the end of the intervention course (post-intervention) by a blinded outcome assessor. Four validated scales were used:

  1. Modified Rankin Scale (mRS): A 7-point global disability scale (0 = no symptoms; 6 = death). A reduction of ≥1 grade was considered clinically meaningful.
  2. Barthel Index (BI): A 10-item functional independence scale (0–100). MCID = 10 points.
  3. FIM-FAM (Functional Independence Measure - Functional Assessment Measure): A comprehensive 30-item functional independence scale assessing motor and cognitive domains (range 30–210). No formally established MCID; reported descriptively.
  4. Fugl-Meyer Assessment (FMA): A comprehensive measure of post-stroke sensorimotor impairment covering motor function, sensation, balance, joint range of motion, and joint pain (total score range 0–226; higher scores indicate better function). ICC = 0.97. A validated MCID for the total scale is not well established; the proportion of patients showing improvement is reported descriptively.

 

Statistical Analysis

Given the small sample size (n=5), both parametric and non-parametric analyses were performed. Paired t-tests compared pre- and post-intervention means; the Wilcoxon Signed-Rank exact test was used as the non-parametric complement. Effect sizes were computed as Cohen’s d (mean change divided by SD of change) and rank-biserial correlation r. The proportion of patients achieving or exceeding the Barthel Index MCID was reported as a responder analysis. All analyses were performed using Python (SciPy v1.11). A p-value of <0.05 was considered statistically significant.

 

RESULTS

Patient Characteristics

Five patients participated in the study (Table 1). Their diagnoses included cerebrovascular accident (CVA) with right hemiplegia (n=2), CVA with left hemiplegia (n=2), and CVA with left hemiplegia and dystonia (n=1). The number of rTMS sessions received ranged from 4 to 24, reflecting variation in duration of hospital admission rather than differences in protocol.

 

Table 1: Patient Characteristics

S.No

Diagnosis

rTMS Sessions

Brunnstrom Stage

mRS Pre

BI Pre

FM Pre

1

CVA, Right Hemiplegia

18

2

5

10

56

2

CVA, Right Hemiplegia

10

2

5

20

58

3

CVA with left hemiplegia and dystonia

4

3

4

55

82

4

CVA, Left Hemiplegia

24

2

5

15

62

5

CVA, Left Hemiplegia

17

3

4

60

83

CVA = Cerebrovascular Accident; FM = Fugl-Meyer Assessment (total score); BI = Barthel Index

 

Functional Outcomes

All five patients demonstrated improvement across all four outcome measures (Table 2). The pattern was strikingly consistent: no patient deteriorated or remained unchanged on any scale. This uniform directionality — reflected in a rank-biserial correlation of 1.00 across all outcomes — speaks not just to statistical significance but to a real-world consistency that is clinically reassuring.

 

Table 2: Pre- and Post-intervention Outcome Scores

Patient

mRS Pre

mRS Post

BI Pre

BI Post

FIM Pre

FIM Post

FM Pre

FM Post

Patient 1

5

4

10

40

74

98

56

85

Patient 2

5

4

20

45

118

139

58

81

Patient 3

4

3

55

75

152

187

82

104

Patient 4

5

4

15

45

124

147

62

89

Patient 5

4

3

60

80

159

188

83

107

Mean±SD

4.6±0.55

3.6±0.55

32.0±23.6

57.0±18.9

125.4±33.7

151.8±37.5

68.2±13.2

93.2±11.6

FM = Fugl-Meyer Assessment (total); BI = Barthel Index

 

Statistical Analysis

Table 3 presents the inferential statistics. Paired t-tests demonstrated highly significant pre-post differences for Barthel Index (t=11.18, p=0.0004), FIM-FAM (t=10.47, p=0.0005), and the Fugl-Meyer Assessment (t=19.17, p<0.001). For mRS, the zero variance in change scores (all patients improved by exactly one grade) renders the t-test undefined (t=∞); the Wilcoxon Signed-Rank exact test yields p=0.0625 the mathematical minimum achievable for n=5 with unidirectional differences, a constraint of sample size rather than evidence of a weak effect.

 

Effect sizes were significant across all scales. Cohen’s d values of 5.00 (BI), 4.68 (FIM-FAM), and 8.58 (FM) place these findings well above the conventional threshold for a ‘large’ effect (d≥0.8). The rank-biserial correlation of 1.00 for all outcomes indicating that every patient improved on every measure without exception is perhaps the most clinically intuitive summary statistic: this combination produced consistent, unidirectional benefit in 100% of participants.

 

Table 3: Statistical Analysis — Pre vs Post rTMS + Conventional Rehabilitation

Scale

Pre Mean±SD

Post Mean±SD

Mean Δ (95% CI)

Paired t (p)

mRS

4.6±0.55

3.6±0.55

−1.0 [−1.0, −1.0]

Undefined; Wilcoxon p=0.0625

Barthel Index

32.0±23.6

57.0±18.9

+25.0 [18.8, 31.2]

0.0004

FIM-FAM

125.4±33.7

151.8±37.5

+26.4 [19.4, 33.4]

0.0005

Fugl-Meyer (total)

68.2±13.2

93.2±11.6

+25.0 [21.4, 28.6]

<0.001

 

Patient 1 presented with complete loss of voluntary movement in his right arm following a CVA, with no voluntary power. In 18 sessions, he went from total dependence to beginning to dress himself. His Barthel Index quadrupled from 10 to 40 points. He described the therapy sessions as the most purposeful activity he had engaged in since his stroke. His Fugl-Meyer score improved by 29 points.

 

Patient 2 CVA, Right Hemiplegia with functionally limiting motor impairment. In 10 sessions, his elbow flexion improved from grade 2 to grade 3, wrist extension from grade 1 to grade 2, and his FIM-FAM score rose from 118 to 139.

 

Patient 3 CVA with left hemiplegia and dystonia had the fewest sessions of all just four, limited by his discharge plan, and yet he showed a 20-point gain in Barthel Index, a 35-point gain in FIM-FAM, and a 22-point gain on the Fugl-Meyer Assessment.

 

Patient 4 CVA with Left Hemiplegia received the most sessions (24), his wrist and finger extension showed the most prominent gains in MRC strength, improving from grade 1 to grade 3 in some muscle groups. His Barthel Index tripled from 15 to 45, and his FIM-FAM rose from 124 to 147.

 

Patient 5 CVA with Left Hemiplegia his hip flexion strength improved from grade 3 to grade 4, and his overall Fugl-Meyer gained 24 points.

 

DISCUSSION

This study documents the application and outcomes of low-frequency rTMS (1 Hz, contralesional M1) combined with conventional rehabilitation in patients with subacute stroke at an Indian tertiary care centre. The results are notable not only for their magnitude but for their consistency — improvement across all four functional scales in all five patients, with every patient exceeding the Barthel Index MCID and achieving large Fugl-Meyer Assessment gains.

 

The mean Fugl-Meyer improvement of 25.0 points, alongside universal gains in functional independence, is consistent with the motor and functional benefits reported when rTMS is combined with conventional rehabilitation (10)(11) and reflects clinically meaningful recovery on a measure with demonstrated responsiveness to change in subacute stroke.(12) The mean BI improvement of 25 points, from a severely dependent baseline mean of 32, represents a shift from severe dependence toward moderate independence. These gains are clinically significant not only statistically but in the lived experience of patients — a 30-point BI gain for Patient 1, for instance, is the difference between complete dependence and the ability to participate in basic self-care.

 

The awareness of interhemispheric competition and its treatment reversal serve as the neurobiological foundation for the benefits seen(13). After a stroke, the lesioned ipsilesional cortex is subjected to excessive transcallosal inhibition and paradoxical overactivity by the undamaged contralesional hemisphere, a maladaptive reaction that hinders motor recovery.(14) Through long-term depression-like mechanisms, low-frequency 1 Hz rTMS reduces this contralesional overactivity, releasing ipsilesional M1 from inhibition.(15) Conventional rehabilitation delivered immediately after rTMS exploits this rebalanced cortical environment: motor practice in a disinhibited ipsilesional cortex promotes stronger activity-dependent synaptic strengthening and more durable functional gains.

 

The variation in session numbers (4–24) across patients offers an instructive observation. Patient 3’s FIM-FAM gain of 35 points in just four sessions suggests that for some patients, a brief course of rTMS combined with conventional rehabilitation may produce disproportionate benefit. It is possibly because the early subacute period represents a window of heightened endogenous neuroplasticity in which rTMS-facilitated interhemispheric rebalancing particularly amplifies spontaneous recovery. Conversely, patient 4’s steady progression over 24 sessions supports the value of a sustained cumulative rTMS dose in patients with denser initial paresis.

 

Low-frequency rTMS is well-tolerated at 90% RMT, and integrates seamlessly into an existing conventional rehabilitation program. The absence of adverse events in this study, including in patients with complex neurological diagnoses supports its safety in the clinical practice. In a healthcare system where neurorehabilitation resources are constrained and therapist-to-patient ratios are often unfavourable, an adjunct that demonstrably amplifies the effects of conventional therapy represents a high-value addition to the rehabilitation armamentarium.

 

Limitations

With n=5, causal inference is not possible. The absence of a control group means that spontaneous recovery, natural history, and non-specific therapist effects cannot be separated from specific rTMS effects. The variation in session numbers and diagnostic mix introduces heterogeneity. These limitations contextualise the findings appropriately and underscore the need for a confirmatory randomised controlled trial.

 

CONCLUSION

Low-frequency rTMS (1 Hz) to contralesional M1 combined with conventional rehabilitation produced clinically meaningful, consistent, and large-magnitude improvements in functional independence and upper limb motor function in all five patients with subacute stroke in this study. Effect sizes far exceeding conventional thresholds and universal MCID achievement support the feasibility and preliminary efficacy of this combination as a practical and accessible neuroplasticity-based rehabilitation strategy. These findings provide the clinical groundwork for a planned multicentre, randomised, sham-controlled trial to confirm these observations with rigorous causal inference.

 

Acknowledgements

The authors thank the patients and their families. We are grateful to the staff of Dept of PMR for their dedication to each patient’s rehabilitation programme. The authors declare no conflicts of interest.

 

REFERENCES

  1. Johnson W, Onuma O, Owolabi M, Sachdev S. Stroke: a global response is needed. Bull World Health Organ. 2016 Sep 1;94(9):634-634A. doi:10.2471/BLT.16.181636
  2. Langhorne P, Coupar F, Pollock A. Motor recovery after stroke: a systematic review. The Lancet Neurology. 2009 Aug;8(8):741–54. doi:10.1016/S1474-4422(09)70150-4
  3. Nakayama H, Jørgensen HS, Raaschou HO, Olsen TS. Recovery of upper extremity function in stroke patients: The Copenhagen stroke study. Archives of Physical Medicine and Rehabilitation. 1994 Apr;75(4):394–8. doi:10.1016/0003-9993(94)90161-9
  4. Zou X, Zhu J, Hu S, Hou Z, Ma G. Application of non-invasive brain stimulation combined with functional magnetic resonance imaging in post-stroke motor function rehabilitation. Journal of Neuroscience Methods. 2025 Sep;421:110470. doi:10.1016/j.jneumeth.2025.110470
  5. Wen X, Liu Z, Zhong L, Peng Y, Wang J, Liu H, et al. The Effectiveness of Repetitive Transcranial Magnetic Stimulation for Post-stroke Dysphagia: A Systematic Review and Meta-Analysis. Front Hum Neurosci. 2022 Mar 17;16:841781. doi:10.3389/fnhum.2022.841781
  6. Hao Z, Wang D, Zeng Y, Liu M. Repetitive transcranial magnetic stimulation for improving function after stroke. Cochrane Stroke Group, editor. Cochrane Database of Systematic Reviews. 2013 May 31. doi:10.1002/14651858.CD008862.pub2
  7. Zhang L, Xing G, Fan Y, Guo Z, Chen H, Mu Q. Short- and Long-term Effects of Repetitive Transcranial Magnetic Stimulation on Upper Limb Motor Function after Stroke: a Systematic Review and Meta-Analysis. Clin Rehabil. 2017 Sep;31(9):1137–53. doi:10.1177/0269215517692386
  8. Juhi A, Gayen RK, Sharma S, Choudhary PK, Mondal H. Repetitive Transcranial Magnetic Stimulation in Stroke Rehabilitation: A Bibliometric Review. Cureus. 2025 Feb 23. doi:10.7759/cureus.79509
  9. Sheng R, Chen C, Chen H, Yu P. Repetitive transcranial magnetic stimulation for stroke rehabilitation: insights into the molecular and cellular mechanisms of neuroinflammation. Front Immunol. 2023 May 22;14:1197422. doi:10.3389/fimmu.2023.1197422
  10. Kang N, Summers JJ, Cauraugh JH. Transcranial direct current stimulation facilitates motor learning post-stroke: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2016 Apr;87(4):345–55. doi:10.1136/jnnp-2015-311242
  11. Ang KK, Guan C, Phua KS, Wang C, Zhou L, Tang KY, et al. Brain-computer interface-based robotic end effector system for wrist and hand rehabilitation: results of a three-armed randomized controlled trial for chronic stroke. Front Neuroeng. 2014 Jul 29;7. doi:10.3389/fneng.2014.00030
  12. Arya KN, Verma R, Garg RK. Estimating the minimal clinically important difference of an upper extremity recovery measure in subacute stroke patients. Topics in Stroke Rehabilitation. 2011 Oct;18(Suppl 1):599–610. doi:10.1310/tsr18s01-599
  13. Kim J, Cha B, Lee D, Kim JM, Kim M. Effect of Cognition Recovery by Repetitive Transcranial Magnetic Stimulation on Ipsilesional Dorsolateral Prefrontal Cortex in Subacute Stroke Patients. Front Neurol. 2022 Jan 31;13:823108. doi:10.3389/fneur.2022.823108
  14. Takeuchi N, Tada T, Toshima M, Chuma T, Matsuo Y, Ikoma K. Inhibition of the unaffected motor cortex by 1 Hz repetitive transcranial magnetic stimulation enhances motor performance and training effect of the paretic hand in patients with chronic stroke. J Rehabil Med. 2008;40(4):298–303. doi:10.2340/16501977-0181
  15. Bunketorp-Käll L, Lundgren-Nilsson Å, Samuelsson H, Pekny T, Blomvé K, Pekna M, et al. Long-Term Improvements After Multimodal Rehabilitation in Late Phase After Stroke: A Randomized Controlled Trial. Stroke. 2017 Jul;48(7):1916–24. doi:10.1161/STROKEAHA.116.016433

 

Recommended Articles
Case Report Open Access
Xanthogranulomatous Pyelonephritis Presenting as Prolonged Constitutional Illness with Obstructive Uropathy and Near-Nonfunctioning Kidney: A Case Report
2026, Volume-7, Issue 3 : 4508-4516
Research Article Open Access
A Prospective Study on the Incidence, Risk Factors, and Clinical Outcomes of Retinopathy of Prematurity in Preterm Neonates Admitted to A Tertiary Care Centre Neonatal Intensive Care Unit at Esic Medical College, Kalaburagi
2026, Volume-7, Issue 3 : 4492-4499
Review Article Open Access
Learner Perspectives on Competency-Based Medical Education in Undergraduate Medicine: A Systematic Review
2026, Volume-7, Issue 3 : 4466-4477
Research Article Open Access
Diagnostic Utility of Non-Contrast Computed Tomography in Traumatic Brain Injury: A Prospective Observational Study at a Tertiary Care Centre in North India
2026, Volume-7, Issue 3 : 4524-4528
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-6, Issue 6
Citations
5 Views
7 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved